Certifications
Transplant Hepatology
Gastroenterology
American Board of Internal Medicine
Clinical Focus
Education
MD, Carol Davila University of Medicine and Pharmacy
Residency, Gastroenterology
Fundeni HospitalResidency, Internal Medicine
Michael Reese HospitalResidency, Internal Medicine
University of IowaFellowship, Gastroenterology
Rhode Island HospitalFellowship, Hepatology (Advanced)
Mount Sinai Hospital
Publications
Gehring S, Gregory SH, Wintermeyer P, Aloman C, Wands JR. Generation of Immune Responses against Hepatitis C Virus by Dendritic Cells Containing NS5 Protein-Coated Microparticles. Clinical and vaccine Immunology 2009; 16: 163-171.
Gehring S, Gregory S, Wintermeyer P, San Martin M, Aloman C, Wands JR. Generation and Characterization of an Immunogenic Dendritic Cell Population. Journal of Immunological Methods 2008; 332: 18-30.
Aloman C, Gehring S, Wintermeyer P, Kuzushita N, Wands JR. Chronic Ethanol Consumption Impairs Cellular Immune Responses Against HCV NS5 Protein Due to Dendritic Cell Dysfunction. Gastroenterology 2007; 132(2): 698-708.
Szabo G, Aloman C, Polyak SJ, Weinman SA, Wands J, Zakhari S. Hepatitis C Infection and Alcohol Use: A Dangerous Mix for the Liver and Antiviral Immunity. Alcoholism: Clinical and Experimental Research 2006; 30(4): 709-719.
Mohr L, Yeung A, Aloman S, Wittrup D, Wands J. Antibody-Directed Therapy for Human Hepatocelullar Carcinoma. Gastroenterology 2004; 127: S225-S231.
Wen F, Abdalla MY, Aloman C, Xiang J, Ahmad IM, Walewski J, McCornmick ML, Brown K, Branch AD, Spitz DR, Brittigan BE, Schmidt W. Increased Prooxidant Production and Enhanced Susceptibility to Glutathione Depletion in HepG2 Cells Co-expressing HCV Core Protein and CYP2E1. Journal of Medical Virology 2004; 72: 230-240.
Aloman C, Wands J. Resistance of HBV to Adefovir Dipivoxil: A Case for Combination Antiviral Therapy?. Hepatology 2003; 38(6): 1584-1587.
Aloman C MD, Tacke F MD. Dendritic Cells in Liver Fibrosis: Conductor of the Inflmmatory Orchestra?. Hepatology 2010 March:1070-1072.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Aloman did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Icahn Medical Institute Floor 11th Floor Room Room 11-70A
1425 Madison Avenue
New York, NY 10029
Fax: 212-849-2574
5 East 98th Street
11th Floor
New York, NY 10029
Fax: 212-241-4465
- Monday 5:00pm - 7:00pm
- Master Card
- Visa
- American Express
- Discover
- Personal Check
- Cash